Vaughan R. Leydon

Medawar Building for Pathogen Research

Papers

1

Total Citations

31

H-Index

1

About

Vaughan R. Leydon is a pioneering biotechnologist whose research centers on antibody discovery and membrane protein biology. His most impactful contribution is the development of a novel mammalian display system for selecting antibodies against membrane proteins in their native conformations—a breakthrough that addresses a long-standing challenge in the field. This work, published in 2020 and garnering 31 citations, enables the reliable generation of specific polyclonal and monoclonal antibodies against targets that are notoriously difficult to study due to their complex, lipid-embedded structures. By allowing antibodies to be selected directly on mammalian cells, Leydon’s method preserves the natural folding and post-translational modifications of membrane proteins, dramatically improving the relevance and utility of the resulting reagents. This innovation has significant implications for both basic research and therapeutic development, particularly in areas like cancer immunotherapy and neurological disorders where membrane proteins are key drug targets. Leydon’s work stands out for its practical elegance, offering a robust platform that bridges the gap between traditional antibody discovery and the pressing need for tools that recognize proteins in their physiological context.

Research Focus

Key Achievements

1
H-Index
1
Papers
31
Total Citations
31
Avg Citations/Paper
🏆 Most Cited Paper
Development of a novel mammalian display system for selection of antibodies against membrane proteins
31 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Medawar Building for Pathogen Research

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago